Washington, DC – Peter G. Shields, MD, deputy director of the Lombardi Comprehensive Cancer Center at Georgetown was elected president-elect of the American Society of Preventive Oncology (ASPO) on August 3. Shields will serve as president-elect for two years before becoming president of the Society in 2011.
ASPO is a multi-disciplinary society whose mission is to promote cancer prevention and control research. Shields, a leading expert in biomarkers of cancer risk and tobacco harm reduction strategies, has previously served as molecular epidemiology interest group chair and conference chair for the Society.
“ASPO is a great organization from which I have benefited and supported in many ways over the years,” says Shields. “I am thrilled to be able to help steer the Society’s direction so that we can make cancer prevention achievable through research, dissemination and implementation.”
Shields’ own research focuses on gene-environment interactions for cancer risk, with a strong emphasis on tobacco-related harm and also separately on breast cancer. The laboratory component of his research develops new biomarkers of cancer risk, while his epidemiological work studies special populations and tests hypotheses related to determining the causes of cancer.
Shields, a member of Lombardi since 2000, is a professor in the departments of oncology and medicine at Georgetown University Medical Center.
ASPO is a multi-disciplinary society whose mission is to promote the exchange and dissemination of information and ideas relating to cancer prevention and control. The Society identifies and stimulates new research areas in cancer prevention and control and supports the implementation and evaluation of national, state, and local programs and policies in cancer prevention and control.
About Lombardi Comprehensive Cancer Center
The Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through Georgetown’s affiliation with MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university’s sponsored research funding.